Back to Resource Center

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya

March 2015

Click to view Journal Article

Click for full info +

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya
March 2015
In this Journal Article:
Health Risk(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy
  • Product Type(s):

  • Hormonal Contraceptives
  • Topic(s):

  • Drug Interactions

  • Full Info:


    Resource Type:

    Journal Article

    Citation:

    Todd, C.S., Deese, J., Wang, M., Hubacher, D., Steiner, M.J., et al. (2015). Contraception, 91(3), 248-252. 

    Authors:

    Todd, C.S., Deese, J., Wang, M., Hubacher, D., Steiner, M.J., et al. 

    Health Risks(s):

    • HIV
    • STI / STD
    • Unintended Pregnancy

    Product type(s):

    • Hormonal

    Topic(s):

    • DrugInteractions

        URL of resource:

        http://www.contraceptionjournal.org/article/S0010-7824%2814%2900732-X/abstract

        Back to Resource Center